Lead enterprise evidence strategy for pipeline and commercial products, developing strategic go to market plans and leading HEOR, RWE, clinical utility, budget impact and cost-effectiveness studies.
Responsibilities
Lead enterprise evidence strategy for pipeline and commercial products
Develop strategic go to market plans which include market horizon scope, competitive analysis, strategic coding and reimbursement opportunity and planning
Lead HEOR, RWE, clinical utility, budget impact and cost-effectiveness studies
Develop and execute strategic payer account plans that expand coverage, contracting, and reimbursement for Baylor Genetics testing, with priority emphasis on WGS-first policies.
Responsibilities
Develop and execute strategic payer account plans that expand coverage, contracting, and reimbursement for Baylor Genetics testing, with priority emphasis on WGS-first policies.
Establish trusted, value-based partnerships with national and regional commercial health plans, Medicare Advantage organizations, Medicaid and Managed Medicaid plans, integrated delivery networks, and other risk-bearing entities.
Lead payer negotiations that translate clinical and economic value into favorable coverage policies, fee schedules, network agreements, value-based arrangements, and administrative pathways.
Create payer-specific value propositions that connect WGS-first testing to improved diagnostic yield, earlier clinical decision-making, reduced serial testing, fewer avoidable procedures, and lower total cost of care.
Partner with HEOR, Medical Affairs, Clinical Affairs, Product, Finance, Revenue Cycle, and Commercial teams to develop evidence strategies, budget-impact models, cost-offset analyses, real-world evidence, and payer-facing value dossiers.
Requirements
Bachelor’s degree in Life Sciences
Bachelor’s degree in Business
Bachelor’s degree in Healthcare Administration
Bachelor’s degree in Public Health
Directeur adjoint, Solutions et pres associée, Stratégie des solutions et
The Associate Director, Solution and Delivery Lead (SDL) serves as a strategic, scientific, and delivery leader within Real World Evidence (RWE) Solutions. This role is accountable for shaping client strategy, driving revenue growth, and ensuring high-quality delivery across complex, multi-offering RWE engagements.
Compensation
La fourchette salariale de base potentielle pour ce poste, annualisée, est de $65,900.00 - $109,800.00. The potential base pay range for this role, when annualized, is $65,900.00 - $109,800.00.
Responsibilities
Lead RWE solution strategy, selling, and delivery oversight for RWE engagements.
Drive RWE sales and revenue growth within key accounts, identifying and advancing cross-selling and upselling opportunities.
Build and sustain senior-level (typically HQ-level) client relationships beyond active engagements to support early positioning and pipeline development for priority assets.
Ensure high-quality, profitable delivery of client projects, leveraging delivery ownership to build long-term client trust.
Apply deep knowledge of the IQVIA RWE portfolio to design integrated, client-specific solutions aligned with evidence needs.
Requirements
Bachelor's, Master’s, or PhD in a scientific discipline (e.g., life sciences, epidemiology, public health, biostatistics, or related field).
The Associate Director, Global Market Access & Pricing will support the development and execution of global market access, reimbursement, and pricing strategies for inline and pipeline assets, with an emphasis on rare disease/orphan products.
Compensation
Expected Base Salary Range: $162,200 - $204,200
Responsibilities
Develop and execute global pricing and market access strategies for assigned assets in partnership with Commercial, Medical, HEOR, and Regulatory.
Lead payer/HTA landscape assessments and targeted payer research to shape the value proposition, define evidence needs, and inform clinical development and evidence plans.
Create and deliver core global access and pricing deliverables, including Global Value Dossiers (GVDs), negotiation strategy guidance, pricing recommendations, and affiliate training/enablement materials.
Support HTA submissions/dossiers and reimbursement negotiations, and monitor evolving policy changes, competitor activity, and pricing/access dynamics to inform strategy updates.
Perform pricing analytics across gross-to-net drivers, contracting/discounting assumptions, price corridors, and international reference pricing (IRP) impacts.
Lead and develop medical affairs strategy for the respiratory therapeutic area across all regions, ensuring alignment with company objectives and cross-functional collaboration.
Compensation
$273,000.00-372,000.00 Annual
Responsibilities
Develop and execute medical affairs plans to support launch and lifecycle management
Provide medical leadership input to cross-functional partners including clinical, operations, HEOR, and commercial
Build external relationship network across therapy area
Develop data generation strategy and gap analysis
Review publications and create medical backgrounders, FAQs and standard responses
Requirements
MD
Nice to have: Board Certified Pulmonologist
Nice to have: Global experience
Nice to have: Experience in multiple regions including the US
The Field Market Access Modeller Specialist develops and adapts health economic models and generates regional-and hospital-specific HEOR evidence to support government affairs and market access activities (dossier preparation, tenders) across Italian regions.
Compensation
The minimum annual base salary for this position is the salary range for this position is € 38.400 - 48.000
Responsibilities
Build, adapt and validate health economic models (e.g. CUA, BIM, cost-effectiveness) using Microsoft Excel
Perform sensitivity and scenario analyses to support regional and hospital access and tender strategies
Translate clinical and economic data into clear and transparent value dossier
Adapt global HEOR models and value narratives to Italian national, regional and local needs
Support regional and local market access activities, including dossier submissions and institutional discussions
Requirements
Master’s degree (or higher) in Health Economics, Pharmacoeconomics or a related field